To Reduce the Deficit, Tariff the Money
To reduce the deficit in a durable way, the United States must do more than tariff goods. It must tariff the money.
New CPA Economic Model Answers Sen. Warren’s Request; Moves Modeling Closer to Reality
The development of GTAP-USL economic model marks another step forward in our efforts to make the GTAP more realistic and a better predictor of the real-world effects of trade policies or trade shocks. It’s critical to build models that provide a better understanding of how policies impact people, families, racial groups, gender, cities and regions. There is still more work to be done.
CPA Commends Trump Administration for Launching Section 301 Investigations Targeting Global Manufacturing Overcapacity, Forced Labor
Section 301 is a powerful tool for addressing foreign policies that distort global markets and disadvantage American producers. When foreign governments explicitly pursue overproduction and then export the resulting surplus into the United States, the effect is to displace domestic output and deter new investment in American manufacturing.
CPA Urges Trump Administration Not To Displace Section 232 Import Relief With New USTR Section 301 Investigations
Section 301 actions against a particular country or group of countries are more likely to merely shift international supply chains as opposed to growing domestic productive output.
Extending AGOA Beyond 2026? Bipartisan, Bicameral Support on Key Committees
The free trade, foreign policy apparatus on Capitol Hill is openly advocating for the extension of the African Growth and Opportunity Act (AGOA), with senior committee leaders from both parties coming out in favor of it during a March 3 Center for Strategic and International Studies event about the trade deal’s future.
India’s Pharmaceutical Quality Issues Could Soon Extend to Generic Versions of Ozempic
Last year, Americans spent more than $15 billion on Novo Nordisk’s diabetes and weight-loss drugs Ozempic and Wegovy. The active ingredient in both treatments — semaglutide— has rapidly become one of the world’s most commercially successful medicines.
Cheap Imports Are Making America Poorer
Cheap imports shaved prices on some goods but never made Americans richer. Wage losses and job destruction outweighed any discounts.
Defense Production Act to Be Part of Re-Industrialization Strategy, House Armed Services Hearing Confirms
On Capitol Hill, the defense narrative clearly gets legislators’ attention. It remains the surest way to get Members of Congress thinking about reindustrialization and rebuilding domestic supply chains.
Why 2025’s Record Breaking Trade Deficit Doesn’t Hurt the Argument for Tariffs
It was no surprise that the 2025 goods deficit broke another record, the Bureau of Economic Analysis (BEA) numbers showed recently. The year-ending goods deficit was $1.24 trillion, up from $1.21 trillion in 2024, with the monthly deficit for December looking like historic averages, nearly $100 billion. Nothing seems to stop America’s appetite for imports.
CPA Praises Launch of First-of-its-Kind Portal Exposing Malign Foreign Funding in U.S. Higher Education
For the first time, the new portal provides the American public with detailed access to reported foreign funding, including gifts and contracts from entities designated as “entities of concern” on nine federal government watchlists.
